Showing results (1131-1140 of 1,195) with videos related to
Sort By:
Pageof 120
Pharmaceutical Statistics|March 10, 2025
BF-BOIN-ET: A Backfill Bayesian Optimal Interval Design Using Efficacy and Toxicity Outcomes for Dose OptimizationKentaro Takeda, Jing Zhu, Akihiro HirakawaPharmaceutical Statistics|October 27, 2024
Treatment Effect Measures Under Nonproportional HazardsDan Jackson, Michael Sweeting, Rose BakerPharmaceutical Statistics|October 24, 2024
PKBOIN-12: A Bayesian Optimal Interval Phase I/II Design Incorporating Pharmacokinetics Outcomes to Find the Optimal Biological DoseHao Sun, Jieqi TuPharmaceutical Statistics|October 16, 2024
Number of Repetitions in Re-Randomization TestsYilong Zhang, Yujie Zhao, Bingjun Wang, et al.Pharmaceutical Statistics|October 8, 2024
An Adaptive Three-Arm Comparative Clinical Endpoint Bioequivalence Study Design With Unblinded Sample Size Re-Estimation and Optimized Allocation RatioDavid Hinds, Wanjie SunPharmaceutical Statistics|September 5, 2024
Propensity Score Analysis With Baseline and Follow-Up Measurements of the Outcome VariablePeter C AustinPharmaceutical Statistics|August 7, 2024
Tutorial on Firth's Logistic Regression Models for Biomarkers in Preclinical SpaceGina D'Angelo, Di RanPharmaceutical Statistics|July 17, 2024
Sample Size Estimation Using a Partially Clustered Frailty Model for Biomarker-Strategy Designs With Multiple TreatmentsDerek Dinart, Virginie Rondeau, Carine BelleraPharmaceutical Statistics|July 10, 2024
Exploring Stratification Strategies for Population- Versus Randomization-Based InferenceMarco Novelli, William F RosenbergerPageof 120